71 – 78 of 78
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 8377 breast cancer patients
- Contribution to journal › Article
-
Mark
Cancer Incidence in BRCA1 mutation carriers
- Contribution to journal › Article
-
Mark
Re: Helicobacter pylori seropositivity as a risk factor for pancreatic cancer
- Contribution to journal › Letter
- 2001
-
Mark
Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer
- Contribution to journal › Article
-
Mark
RESPONSE: Re: High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families
- Contribution to journal › Letter
-
Mark
Re: CYP17 promoter polymorphism and breast cancer in Australian women under age forty years
- Contribution to journal › Letter
- 1999
-
Mark
Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer
- Contribution to journal › Article
- 1994
-
Mark
High frequency of allelic imbalance at the BRCA1 region on chromosome 17q in both familial and sporadic ductal carcinomas
- Contribution to journal › Article
